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Abstract
The lateral habenula (LHb) has recently emerged as a key brain region in the pathophysiology of
depression. However the molecular mechanism by which LHb becomes hyperactive in depression
remains unknown. Through a quantitative proteomic screen, we found that βCaMII expression was
significantly upregulated in the LHb of animal models of depression, and downregulated by
antidepressants. Increasing the levels of β- but not α-CamKII in the LHb strongly enhanced the
synaptic efficacy and spike output of LHb neurons, and was sufficient to produce profound
depressive symptoms including anhedonia and behavioral despair. Downregulation of βCaMKII
levels, blocking its activity or its target molecule GluR1, reversed the depressive symptoms. These
results identify βCaMKII as a powerful regulator of LHb neuron function and a key molecular
determinant of depression.
Major depressive disorder (MDD), one of the most prevalent and disabling mental disorders,
is characterized by low mood, loss of motivation, feelings of despair, and an inability to feel
pleasure, also known as anhedonia (1). Modern views on the cause of MDD suggest that the
neural activity of specific brain circuits are altered in response to external stimuli such as
stress, as a result of maladaptive molecular and cellular changes (2, 3). Recently, the lateral
habenula (LHb), a nucleus that relays information from the limbic forebrain to multiple
monoamine centers, has emerged as a key brain region in aversive behaviors and the
pathophysiology of depression (4–10). LHb neurons are activated by aversive emotional
cues, including stress, disappointment, fear or anticipation of a negative reward (4–6).
Consistently, neuroimaging studies have identified heightened habenula activity in the
depressed state (11–13). Furthermore, synaptic activity and spike output of LHb neurons
were enhanced in animal models of depression (14). However, what molecular mechanisms
underlie these aberrant cellular processes in LHb and how depression-inducing stimuli lead
to these changes are yet to be determined.
*To whom correspondence should be addressed. hailan@ion.ac.cn.
#These authors contributed equally to this work§Current address: Institute of Biochemistry and Cell Biology, National Center for Protein Science, Shanghai Institutes for Biological
Sciences, Chinese Academy of Sciences, Shanghai 200031, P.R. China
NIH Public Access
Author Manuscript
Science. Author manuscript; available in PMC 2014 February 24.
Published in final edited form as:
Science. 2013 August 30; 341(6149): 1016–1020. doi:10.1126/science.1240729.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
We conducted an unbiased, mass spectrometry-based, quantitative proteomic screening, to
compare habenular protein expression of wild-type control and congenitally learned helpless
(cLH) rats, a well-accepted model of depression (15)). cLH rats were selectively bred for the
phenotype of learned helplessness (16), displaying significantly reduced escape from
escapable foot shocks, which was reversible by chronic antidepressant treatment
(imipramine, i.p.,10mg/kg, 14 days, Fig. 1A). cLH rats also showed increased immobility in
the forced swim test (Fig. 1A), another animal model of depression that reflects behavioral
despair (17), though basic motor and cognitive functions are normal (15).
We micro-dissected the habenuli of cLH and wild-type control rats and extracted protein for
quantitative proteomic analysis based on 15N stable isotope labeling (Fig. 1B, 18). To reduce
sample complexity, the membrane fraction was extracted and three independent sets of
samples were analyzed (figs. S1-3, table S1). We identified βCaMKII as significantly
upregulated in the habenula of cLH rats (1.9-fold of wild-type control, p = 0.01, Fig.1C).
Other CaMKII family isoforms were also examined: αCamKII levels varied widely across
samples although an increasing trend was observed; δCaMKII remained unchanged;
γCaMKII showed a 1.3-fold increase (p = 0.0013, fig. S4). As βCaMKII is more enriched in
the brain than γCaMKII (19, 20), we focused on this CaMKII isoform. Secondary validation
by western blot analysis confirmed that βCaMKII in the membrane fraction of cLH
habenular protein samples increased to 1.86-fold of the control level (p = 0.03, Fig. 1D). In
contrast, the βCaMKII protein level in cLH hippocampal samples decreased (63% of
control, p = 0.048, Fig. 1E), probably due to neural atrophy and spine loss in the
hippocampus associated with depression (21, 22). Levels of βCaMKII mRNA in cLH
habenula increased to 1.37-fold of control (p = 0.04) as measured by quantitative real-time
PCR (Fig. 1F), suggesting that transcriptional regulation contributed to at least part of the
protein level change. Immunohistochemical staining of habenular brain slices revealed that
the CaMKII protein level increase occurred in the lateral part of the habenula (fig. S6).
We further examined βCaMKII level in two additional depression models, acute learned
helpless, induced by repeated inescapable and uncontrollable foot shocks (16), and chronic
mild stress, induced by prolonged exposure to unpredictable mild stressors (23). The
βCaMKII levels were also significantly increased in these two stress paradigms (Fig. 1G).
Furthermore, chronic antidepressant treatment with imipramine, which reversed the
depressive phenotypes of cLH rats (Fig. 1A), caused significant downregulation of
βCaMKII protein in the habenula of cLH rats (Fig. 1H).
We next investigated to what extent the change of βCaMKII levels in LHb is necessary or
sufficient to cause depressive behaviors, or whether it is merely a biological marker of the
depressive state. We first constructed viral vectors (adeno-associated virus 2 (AAV2)) to
overexpress β- or α- CamKII in the LHb of wild-type rats and mice, and tested the effects on
various depression models (Figs. 2A-C). We used the ubiquitin promoter to drive
ubiquitous, high-level gene expression, as LHb neurons are almost uniformly glutamatergic
(24). To estimate the level of overexpression, we injected CaMKII-expressing viruses into
one side of the habenula. At 14 days post injection, CaMKII levels in the injected side were
4.4 ± 0.6-fold for AAV-βCaMKII and 4.6 ± 0.9-fold for AAV- αCaMKII of the non-injected
side respectively (fig. S6). We then injected virus into both sides of LHb and allowed
expression for 10 days before proceeding to behavioral tests of depression (Figs. 2B, 2C, fig.
S7).
Overexpression of βCaMKII in the LHb of unstressed mice produced significantly increased
immobility time and decreased latency to immobility onset in the forced swim test,
compared with the injection control (Fig. 2D). Locomotor activities of these mice were not
significantly different (fig. S8), indicating that the immobility was unlikely due to motor
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defects. In addition, βCaMKII overexpression also caused anhedonia, evident from a
significant reduction in the preference for the sucrose solution (Fig. 2E). To estimate the
minimal infection rate required to produce the depression phenotype, we bilaterally injected
an additional group of mice with 1:10 diluted AAV-βCaMKII virus. Unlike the normal
injection group (infection rate = 38 ± 3%), this sparse injection group (infection rate = 5 ±
0.6%) did not exhibit depressive phenotypes (fig. S9). Overexpression of αCaMKII, or a
control GFP-Cre construct, at a similar infection rate (36 ± 2.5% for αCaMKII, 36 ± 3% for
GFP-Cre) did not cause similar depressive effects (Fig. 2 D-E). βCaMKII can act both as a
kinase and a structural scaffolding protein at the synapses (25). A kinase-dead version of
βCaMKII, βK43R (26), even when overexpressed at a similar level as wild-type βCaMKII
(4.6 ± 0.5-fold, infection rate = 40 ± 3%, fig. S6), did not cause depressive-like phenotypes
(Figs. 2D, 2E), suggesting that the kinase function of βCaMKII was required to produce
depression. Furthermore, in rats, overexpression of βCaMKII in the LHb significantly
increased immobility in the forced swim test and reduced the escape behavior, as indicated
by number of bar pressing to terminate foot shocks in the learned helplessness test (Figs. 2F,
2G).
To investigate the cellular mechanism by which βCaMKII overexpression alters LHb neuron
activity and function, we performed paired whole-cell patch-clamp recordings on viral-
infected and neighboring uninfected LHb neurons in acute brain slices of wild-type rats (Fig.
3A). First, to examine the synaptic property of LHb neurons, we measured the miniature
excitatory postsynaptic currents (mEPSCs), which are mediated by the α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) subtype of glutamate receptors and
reflect individual synaptic responses onto recorded neurons. In non-infected brain slices,
neighboring LHb neuron pairs showed highly similar mEPSC frequency, despite
heterogeneity across different sub-regions of the LHb (fig. S10). In neurons infected by
AAV-βCaMKII, mEPSC frequency was greatly increased (351 ± 51% of neighboring
controls, p = 0.0001), as was mEPSC amplitude (130 ± 10% of controls, p = 0.007, Figs. 3B,
3C). In contrast, AAV-αCaMKII infection caused a slight decrease in mEPSC frequency (81
± 9% of controls, p = 0.08), and no change in mEPSC amplitude (87 ± 5% of controls, p =
0.16, Figs. 3B, 3D). The effects on mEPSC frequency largely resembled what has been
shown in hippocampal neurons for these two CaMKII isoforms (27). Further, to examine the
output of these LHb neurons, we measured the spontaneous spiking rate in a cell-attached
configuration. The AAV-βCaMKII-infected neurons exhibited a 3.0-fold increase in spiking
rate compared with neighboring uninfected neurons (p = 0.0004, Figs. 3E, 3F), whereas no
such change was detected for AAV-αCaMKII (p = 0.7, Fig. 3G), or AAV-GFP-infected (p =
0.95, Fig. 3H) neurons.
To determine whether down-regulation of βCaMKII levels or blockade of βCaMKII
functions in LHb reversed depressive phenotypes, we first employed RNA interference
(RNAi) to knock down βCaMKII protein level (Fig. 4A). A previously reported short
hairpin RNA specifically targeting the βCaMKII transcript can effectively reduce βCaMKII
protein levels without affecting αCaMKII (28, Fig. 4B). We then expressed this RNAi form
of βCaMKII in AAV virus (AAV-βRNAi) and targeted its expression to the LHb of cLH rats
by bilateral stereotactic injection (Fig. 4C). In cLH rats infected by AAV-βRNAi, the
immobility time in the forced swim test was markedly reduced (p < 0.001) and the escape
behavior in the learned helpless test significantly increased (p < 0.05, Figs. 4D, 4E). The
percentage of learned helpless animals (defined as those with less than 5 bar pressing)
dropped from 83.3% to 25% (Fig. 4F).
To rule out potential off-target effects by RNAi, we further tested a kinase-dead version of
βCaMKII, βK43R, which acts as a dominant-negative to block endogenous βCaMKII
function when overexpressed (26, Fig. 2A). When AAV-βK43R virus was injected into the
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LHb of cLH rats, similar anti-depression effects as AAV-βRNAi were observed in both the
forced swim and learned helplessness tests (Figs. 4D-4F). Intriguingly, an infection rate as
low as 17 ± 3% for AAV-βRNAi or 24 ± 3% for AAV-βK43R was sufficient to achieve
these strong anti-depression effects, suggesting that LHb neural network has little
redundancy, and that altering the activity of a relatively small percentage of LHb neurons is
sufficient to ameliorate depression. We thus further analyzed infection within sub-regions of
LHb, and found that infection rates in the medial, but not lateral part of LHb were strongly
correlated with the rescuing effects on learned helplessness (Fig. 4G). In the LHb brain
slices of cLH rats, neurons infected by the AAV-βRNAi showed significantly reduced
frequency of mEPSC (53.5 ± 15.3% of neighboring uninfected controls, p = 0.008, Fig. 4H).
What could be the downstream molecular targets of βCaMKII in mediating the LHb
hyperactivity in depression? Upregulation of βCaMKII increases the synaptic expression and
delivery of GluR1-type AMPAR in cultured hippocampal neurons (29). Thus, we examined
the level of GluR1 in the LHb of cLH rats, and found that the membrane fraction of GluR1
was upregulated (222 ± 41.7% of controls, p < 0.01, fig. S11A). Conversely, in cLH rats
treated with antidepressant imipramine, the membrane GluR1 level was decreased (72 ± 8%
of controls, p = 0.003, fig. S11B). To test the role of GluR1 in βCaMKII–mediated
depression, we co-expressed βCaMKII with a dominant negative form of GluR1, GluR1Ct,
which blocks the synaptic trafficking of GluR1 (30, 31), using an AAV-βCaMKII-2A-
GluR1Ct viral construct. Expression level tests based on unilateral injection revealed that
βCaMKII exhibited a 3.8-fold and GluR1Ct a 3.7-fold overexpression of endogenous levels
(fig. S11C). When this virus was bilaterally injected into the LHb of wild-type mice
(infection rate 37 ± 2%), mice performed normally in both the forced swim and sucrose
preference tests (figs. S11, D, E). Therefore coexpression of GulR1Ct prevented the
depressive effects of βCaMKII overexpression.
Here we identified βCaMII as a key molecular determinant of habenular hyperactivity and
behavioral depression, using a combination of molecular, behavioral and
electrophysiological approaches. Our results point to a model in which stress-induced
upregulation of βCaMII in the LHb causes more GluR1 insertion into synapses, resulting in
increased synaptic efficacy. In addition, βCaMII may regulate other channels and membrane
properties of LHb neurons to enhance spike output, which work in concert to cause LHb
hyperactivity, leading to enhanced suppression of downstream monoamine centers (fig.
S12A). Previous studies have implicated changes in CaMKIIs related to stress and
antidepressant response (32–35). However it was unclear whether these changes are
necessary or sufficient for depression etiology, and which brain region or isoform is crucial
(36). βCaMKII is about eightfold more sensitive to Ca/calmodulin than αCaMKII (37), and
possesses an actin-binding motif that is absent in αCamKII (38). It will be interesting to
pinpoint in the future which feature of βCaMII renders this isoform-specific function in
depression.
An important future question is how depressive stimuli and antidepressants lead to
bidirectional changes in βCaMII levels in the LHb. Aversive emotional stimuli activate LHb
neurons (4–6), whereas serotonin boosted by antidepressants suppresses excitatory inputs
onto the LHb (7). Thus it is tempting to speculate that βCaMII levels are regulated by LHb
neural activity. During the onset of depression, prolonged activation of LHb neurons may
cause the upregulation of βCaMII to reach a threshold level, which can lead to further LHb
neural activation. Conversely, antidepressant-caused suppression of the LHb may
downregulate βCaMII levels, which can further lower LHb activity. These self-reinforcing
feedback processes may eventually drive long-term adaptive changes in emotional states.
Whether and how neuronal activity regulates βCaMII expression awaits further
investigation.
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In the context of our finding that the medial part of the LHb (LHb-M) is critical for the
rescue of learned helplessness behavior (Fig. 4G), it is relevant to note that stress-induced c-
fos activation is relatively confined to the LHb-M (4), and that there were more neurons
with higher mEPSC frequency in LHb-M than those in LHb-L (fig. S10A). Further, LHb-M
and LHb-L have different circuit wiring, which could contribute to their differential
involvement in aversive behaviors and depressive symptoms (fig. S12B). Molecular
manipulations in the nucleus accumbens (NAc) specifically mediate anhedonia but not
behavioral despair (39). We found manipulation of βCaMII levels in the LHb affected both
of these symptoms, suggesting that LHb may function upstream of NAc in the depression-
related circuitry to control multiple aspects of depressive symptoms. Hence, the molecular
targets identified in the LHb in this study should provide new insights for therapies that treat
both of these core symptoms of depression.
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Fig. 1. βCaMKII is upregulated in the LHb of animal models of depression
(A) Depression phenotypes of cLH rats. Numbers in the bars indicate number of animals
used. Note in LH test, maximal number of bar presses is 15. (B) Experimental outline of the
high-throughput quantitative proteomics based on stable isotope labeling. Briefly, habenula
of unlabeled (14N) WT or cLH rats were dissected, homogenized, and mixed in a 1:1 ratio
with total brain homogenate from a 15N-labeled rat. Membrane fraction was enriched, and
100 µg protein sample was used for standard mass spectra analysis. 14N /15N ratio for each
identified peptide was calculated. Peptide ratios for each protein were then compared
between cLH and control sample. Details see methods. (C) Proteomic analysis of βCaMKII,
based either on total peptides, or unique peptides (peptides not shared by other CaMKII
family members) identified in 3 independent proteomic runs. (D, E) Western blot analysis
showing change of βCaMKII in membrane fraction of habenula (D) or hippocampus (E) of
cLH rats. Tissue amounts of tubulin were used as loading control. Protein expression was
normalized by control amount. (F) qPCR analysis of βCaMKII mRNA in habenula. (G)
βCaMKII level increase in acute learned helpless and chronic mild stress (CMS) depression
models. aLH and aNLH were rat groups subjecting to LH stress but did (aLH), or did not
(aNLH) display LH symptom. (H) Western blot analysis showing level of βCaMKII in
membrane fraction of habenula of cLH rats treated with saline or antidepressant imipramine.
Data are mean ± SEM. * p < 0.05 ** p < 0.01, *** p < 0.001 compared to control group,
n.s., not significant, two-tailed Student’s t-tests for two-group comparison, one-way
ANOVA with Bonferroni post hoc analysis for multiple-group comparison.
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Fig. 2. Overexpression of βCaMKII but not αCaMKII in LHb caused depressive-like behaviors
in both mice and rats
A) Schematics of AAV vectors engineered to overexpress a control construct, βCaMKII,
αCaMKII, or a kinase-dead mutant of βCaMKII. ITR, inverted terminal repeats; CMV,
cytomegalovirus promoter; Ubi: ubiquitin promoter; 2A: viral 2A linker peptide allowing
translation of multiple unfused proteins. (B) Experimental paradigm for behavioral testing of
WT mice or rats. (C) Illustration of bilateral viral injection of AAV-βCaMKII in mouse LHb
(counter-stained with anti-GFP and nuclear marker Hoechst). Scale bars, 50 µm. (D-G)
Behavioral effects of expressing various viral constructs in LHb in animal models of
depression in mice (D-E) or rats (H, I). * p < 0.05, ** p < 0.01, *** p < 0.001 compared
with non-injected WT, # p < 0.05, ## p < 0.01 compared with AAV-control, one-way
ANOVA with Bonferroni post hoc analysis.
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Fig. 3. Overexpression of βCaMKII increased synaptic activity and spike output of LHb neurons
(A) Schematics of paired recording configuration in LHb (left). Right: paired patching of a
βCaMKII-infected LHb neuron (pointed by green arrow) and a neighboring uninfected
neuron (pointed by red arrow) under transmitted and fluorescent light microscopy. Scale
bars, 10 µm. (B) Example mEPSC traces, measured in a whole-cell configuration, from LHb
neurons of control neurons, or neurons infected by AAV-βCaMKII or AAV-αCaMKII. (C,
D) Cumulative distribution of mEPSC inter-events interval and average frequency (left), or
mEPSC amplitude (right) of neurons infected by AAV-βCaMKII (C) or AAV-αCaMKII
(D). Each line represents values from a pair of control and neighboring viral-infected
neurons. (E) Example traces of spontaneous spiking, measured in a cell-attached
configuration, from LHb neurons of control neurons, or neurons infected by AAV-βCaMKII
or AAV-αCaMKII. (F - H) Average spontaneous spiking frequency of neurons infected by
AAV-βCaMKII (F), AAV-αCaMKII (G), or AAV-GFP (H). ** p < 0.01, *** p < 0.001,
Wilcoxon signed-rank test.
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Fig. 4. Knocking-down of βCaMKII in LHb rescued depression-like phenotypes of cLH rats and
reduced synaptic activity of LHb neurons
(A) Schematics of the AAV vector engineered to overexpress an RNAi form of βCaMKII.
H1: human H1 promoter. (B) Specific knocking down of βCaMKII but not αCaMKII by the
βCaMKII RNAi construct. pSuper-βCaMKII-RNAi construct was co-transfected with AAV-
βCaMKII or AAV-αCaMKII plasmid in 293TN cells, and expressed for 48 hrs before
Western analysis. Left: representative western blot. Right: quantification of knock down
efficiency. (C) Experimental paradigm for behavioral testing of cLH rats infected by virus.
(D-E) Behavioral effects of expressing AAV-βRNAi and AAV-βK43R in the LHb of cLH
rats in forced swim (D) or learned helpless test (EF). * p < 0.05, *** p < 0.001, one-way
ANOVA with Bonferroni post hoc test. (F) Percentage of animals in each category. LH:
learned helpless rats with ≤ 5 lever presses. NLH: non-learned helpless rats with ≥10 lever
presses. (G) Sub-regional characterization of viral infection. Top: illustration of the division
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of lateral LHb (LHb-L) and medial LHb (LHb-M) in an AAV-βRNAi virus infected cLH rat
brain slice. Scale bar, 100 µm. Bottom: Behavioral response in the learned helpless test
plotted against infection rates in the LHb-L and LHb-M of cLH rats. (H) mEPSCs of AAV-
βRNAi infected LHb neurons from cLH rats were altered. Top: example mEPSC traces.
Cumulative distribution of mEPSC inter-events interval and average frequency (bottom left)
or mEPSC amplitude (bottom right) of cLH LHb neurons infected by AAV-βRNAi. * p <
0.05, ** p < 0.01, *** p < 0.001 compared with cLH/AAV-control, Wilcoxon signed-rank
test.
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